Clinical trial
Impact of Intra-Arterial PSMA Injection on Distribution and Tumor Uptake: Texture Analysis and Dose Radicality Prediction in Prostate Cancer
NCT07656337 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Intra-Arterial PSMA Injection on Distribution and Tumor Uptake: Texture Analysis and Dose Radicality Prediction in Prostate Cancer
- Lead sponsor
- Lithuanian University of Health Sciences
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- October 31, 2028
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate adenocarcinoma, prostate cancer